UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Isolation and characterization of urinary extracellular vesicles: implications for biomarker discovery

Nature reviews. Nephrology, 2017-12, Vol.13 (12), p.731

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome

Kidney international, 2010-10, Vol.78 (8), p.810-816

2010

Link zum Volltext

Verfügbarkeit prüfen

Serum suPAR in patients with FSGS: trash or treasure?

Pediatric nephrology (Berlin, West), 2013-07, Vol.28 (7), p.1041-1048

2013

Link zum Volltext

Verfügbarkeit prüfen

Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis

Kidney international, 2008-12, Vol.74 (12), p.1568-1576

2008

Link zum Volltext

Verfügbarkeit prüfen

A retrospective study of focal segmental glomerulosclerosis: clinical criteria can identify patients at high risk for recurrent disease after first renal transplantation

BMC nephrology, 2013-02, Vol.14 (1), p.47-47, Article 47

2013

Link zum Volltext

Verfügbarkeit prüfen

Primary Focal Segmental Glomerulosclerosis Plasmas Increase Lipid Droplet Formation and Perilipin-2 Expression in Human Podocytes

International journal of molecular sciences, 2022-12, Vol.24 (1), p.194

2022

Link zum Volltext

Verfügbarkeit prüfen

Pathological variants of focal segmental glomerulosclerosis in an adult Dutch population—epidemiology and outcome

Nephrology, dialysis, transplantation, 2008-01, Vol.23 (1), p.186-192

2008

Link zum Volltext

Verfügbarkeit prüfen

Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy

Nephrology, dialysis, transplantation, 2008-08, Vol.23 (8), p.2546-2551

2008

Link zum Volltext

Verfügbarkeit prüfen

The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis

Kidney international, 2014-03, Vol.85 (3), p.636-640

2014

Link zum Volltext

Verfügbarkeit prüfen

Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy

Nephrology, dialysis, transplantation, 2008-10, Vol.23 (10), p.3160-3165

2008

Link zum Volltext

Verfügbarkeit prüfen

Rituximab: effective treatment for severe steroid-dependent minimal change nephrotic syndrome?

Nephrology, dialysis, transplantation, 2007-07, Vol.22 (7), p.2100-2102

2007

Link zum Volltext

Verfügbarkeit prüfen

Serum-soluble urokinase receptor concentration in primary FSGS

Kidney international, 2012-05, Vol.81 (10), p.1043-1044

2012

Link zum Volltext

Verfügbarkeit prüfen

Genetic causes of focal segmental glomerulosclerosis: implications for clinical practice

Nephrology, dialysis, transplantation, 2012-03, Vol.27 (3), p.882-890

2012

Link zum Volltext

Verfügbarkeit prüfen

Nephrotic Syndrome With Mutations in NPHS2: The Role of R229Q and Implications for Genetic Counseling

American journal of kidney diseases, 2019-03, Vol.73 (3), p.400-403

2019

Link zum Volltext

Verfügbarkeit prüfen

Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy

Nephrology, dialysis, transplantation, 2007-08, Vol.22 (8), p.2201-2207

2007

Link zum Volltext

Verfügbarkeit prüfen

Membranous nephropathy in the older adult : Epidemiology, diagnosis and management

Drugs & aging, 2007-01, Vol.24 (9), p.717-732

2007

Link zum Volltext

Verfügbarkeit prüfen

Kidney Disease Associated With Mono-allelic COL4A3 and COL4A4 Variants: A Case Series of 17 Families

Kidney medicine, 2023-04, Vol.5 (4), p.100607-100607, Article 100607

2023

Link zum Volltext

Verfügbarkeit prüfen

Later Response to Corticosteroids in Adults With Primary Focal Segmental Glomerular Sclerosis Is Associated With Favorable Outcomes

Kidney international reports, 2022-01, Vol.7 (1), p.87-98

2022

Link zum Volltext

Verfügbarkeit prüfen

Serum suPAR concentrations in patients with focal segmental glomerulosclerosis with end-stage renal disease

Kidney international, 2014-03, Vol.85 (3), p.711-711

2014

Link zum Volltext

Verfügbarkeit prüfen

Immunosuppressive treatment of focal segmental glomerulosclerosis: lessons from a randomized controlled trial

Kidney international, 2011-10, Vol.80 (8), p.798-801

2011

Link zum Volltext

Verfügbarkeit prüfen

B Cell Suppression in Primary Glomerular Disease

Advances in chronic kidney disease, 2014-03, Vol.21 (2), p.166-181

2014

Link zum Volltext

Verfügbarkeit prüfen

NMR and MS urinary metabolic phenotyping in kidney diseases is fit-for-purpose in the presence of a protease inhibitor

Molecular omics, 2019-02, Vol.15 (1), p.39-49

2019

Link zum Volltext

Verfügbarkeit prüfen

Rituximab for plasma exchange-dependent recurrent focal segmental glomerulosclerosis after renal transplantation

Clinical kidney journal, 2008-04, Vol.1 (2), p.85-88

2008

Link zum Volltext

Verfügbarkeit prüfen

Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplantation

Transplant international, 2004-03, Vol.17 (3), p.151-157

2004

Link zum Volltext

Verfügbarkeit prüfen

Genetic causes of focal segmental glomerulosclerosis: implications for clinical practice

Nephrology, dialysis, transplantation, 2012-03, Vol.27 (3), p.882-890

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(42)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(34)
Science & Technology
(34)
Humans
(29)
Urology & Nephrology
(28)
Female
(17)
Adult
(16)
Male
(15)
Transplantation
(15)
Nephrology
(13)
Focal Segmental Glomerulosclerosis
(12)
Middle Aged
(12)
Biological And Medical Sciences
(11)
Medical Sciences
(11)
Aged
(7)
Glomerulonephritis
(7)
Prognosis
(7)
Recurrence
(7)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(6)
Emergency And Intensive Care: Renal Failure. Dialysis Management
(6)
Intensive Care Medicine
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Isolation and characterization of urinary extracellular vesicles: implications for biomarker discovery

Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome

Serum suPAR in patients with FSGS: trash or treasure?

Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis

A retrospective study of focal segmental glomerulosclerosis: clinical criteria can identify patients at high risk for recurrent disease after first renal transplantation

Primary Focal Segmental Glomerulosclerosis Plasmas Increase Lipid Droplet Formation and Perilipin-2 Expression in Human Podocytes

Pathological variants of focal segmental glomerulosclerosis in an adult Dutch population—epidemiology and outcome

Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy

The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis

Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy

Rituximab: effective treatment for severe steroid-dependent minimal change nephrotic syndrome?

Serum-soluble urokinase receptor concentration in primary FSGS

Genetic causes of focal segmental glomerulosclerosis: implications for clinical practice

Nephrotic Syndrome With Mutations in NPHS2: The Role of R229Q and Implications for Genetic Counseling

Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy

Membranous nephropathy in the older adult : Epidemiology, diagnosis and management

Kidney Disease Associated With Mono-allelic COL4A3 and COL4A4 Variants: A Case Series of 17 Families

Later Response to Corticosteroids in Adults With Primary Focal Segmental Glomerular Sclerosis Is Associated With Favorable Outcomes

Serum suPAR concentrations in patients with focal segmental glomerulosclerosis with end-stage renal disease

Immunosuppressive treatment of focal segmental glomerulosclerosis: lessons from a randomized controlled trial

B Cell Suppression in Primary Glomerular Disease

NMR and MS urinary metabolic phenotyping in kidney diseases is fit-for-purpose in the presence of a protease inhibitor

Rituximab for plasma exchange-dependent recurrent focal segmental glomerulosclerosis after renal transplantation

Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplantation

Genetic causes of focal segmental glomerulosclerosis: implications for clinical practice

Suchergebnisse filtern